Salix Announces 2022 Gastrointestinal Health Scholars Program

Go back to Salix Announces 2022 Gastrointestinal Health Scholars Program

RBC Capital Sees Positive Read-Through to Bausch Health Companies (BHC) from Alcon's (ALC) EPS

February 16, 2022 10:15 AM EST

RBC Capital analyst Doug Miehm reiterated an Outperform rating and $34.00 price target on Bausch Health Companies (NYSE: BHC).

The analyst comments "Alcon reported strong Q4/21 results with revenues at $2.13B (+10.9% y/y) ahead of consensus($2.10B). Surgical segment revenues grew... More